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Results
Agreement CCR versus APDC
•Overall agreement  between CCR and APDC 
for identification of MBC was 98%, 
agreement beyond chance was 87%.
• After CCR review, 701 subjects were 
classified as having MBC, giving a 
cumulative incidence proportion of 10.3% 
(95%CI 9.6-11.0%), compared with 9.9% 
(95%CI 9.2-10.6%), prior to review.
• The CCR yielded an additional 44 MBC 
than the APDC, identifying 669 verified MBC 
including 76 cases not detected from APDC, 
whereas APDC identified 625 MBC including 
32 cases not detected from CCR (p<0.0001).
Time to first MBC
• 82% of CCR notifications occurred at or 
within 3 months of the first APDC record, 
11% occurred >3 months before the APDC 
record, and 7% >3 months after APDC 
record (p=0.04).
Methods
Study population
• We used the CCR to identify all cases of 
non-metastatic breast cancer diagnosed in 
NSW in 2001-2002. 
• We used health record linkage (HRL) to 
identify APDC records for this study cohort 
up to 31 December 2007.
Outcome
New metastatic breast cancer (MBC) 
identified by CCR or APDC within 5-years of 
primary breast cancer diagnosis (see table 
for definitions).
Analysis
• We calculated agreement between CCR 
and APDC for defining MBC status at 5 yrs.
• A clerical review of cases recorded as MBC 
on one but not both databases (‘discordant’ 
records) was performed at the CCR.
•We compared the yield of CCR-verified 
MBC cases and timing of first notification 
between each data source (McNemars test).
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Study objective
To assess agreement between the NSW 
Central Cancer Registry (CCR) and the 
NSW Admitted Patient Data Collection 
(APDC) for identification of progression 
to metastatic disease in women with 
breast cancer. 
Introduction
• Population-based estimates of rates of 
progression to metastatic cancer are 
important for doctors, patients and 
health service planning.
• State cancer registries receive 
notifications of new cancer diagnoses, 
but notifications of metastases are not 
routinely validated.
•Hospitals also record diagnoses of 
secondary (metastatic) cancers.
•Record linkage of cancer registry and 
hospital data can be used to estimate 
rates of progression, however the validity 
of this approach has not been reported.
NSW Central Cancer Registry
(CCR)
NSW Admitted Patient Data 
Collection (APDC)
Data sources
• Receives cancer notifications for 
NSW residents from hospitals, 
pathology laboratories, and 
radiotherapy units.
• Records information including: 
diagnosis date, degree of spread
(localised, regional, distant, 
unknown); tumour site; and 
morphology.
• Records ICD-10 AM diagnosis and 
procedure codes for every hospital 
episode of care in NSW.
Study definition of metastatic breast cancer (MBC) 
• Notification with degree of spread 
classified as distant following an 
initial diagnosis of non-MBC. 
• Coded by hospital coder or  
pathology laboratory, or if this
classification is missing, ICD-10AM 
diagnosis codes for C78 and C79 are 
used. 
• Diagnosis of secondary malignant 
cancer (C77-C79, excluding C77.3-
secondary and unspecified malignant 
neoplasm of lymph nodes and C79.81-
secondary cancer of breast) 
• CCR-verification required if known 
other non-breast cancer
Interpretation
• This study  provides the first 
information on the validity of using CCR 
and APDC records to estimate breast 
cancer progression to metastatic disease 
at the population level.
• The high agreement between the CCR 
and APDC for MBC detection and timing  
illustrate hospital notifications are the 
major source of CCR notifications.
• The CCR holds more complete data, 
which is a particular advantage for 
determining MBC status in subjects with 
multiple primaries. For verified MBC, it 
identified a further 6.3% of cases than the 
APDC, with an associated small increase 
(0.65%) in 5-year MBC risk.
Conclusions
The overall accuracy of the CCR and APDC 
for detecting the first clinical diagnosis of 
MBC is unknown, however our findings 
suggest both are feasible sources for 
estimating risk of MBC requiring hospital 
care. 
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CCR review of MBC recorded on one database only
CCR only N=81 APDC only N=85
Verified as MBC, n=76 Verified as MBC, n=32
• Notification included from NSW 
hospitals, n=48
• Notification only from non-NSW 
hospitals, n=28, including: interstate 
notification (10); pathology (15), 
XRT (2), death (1)
• CCR coding of loco-regional spread 
revised to MBC, n=14
• CCR notification received after 5 
years, n= 6
• MBC  only recorded on death 
certificate, n=12
Revised to non-MBC, n=5 Revised to non-MBC, n=53
• Secondary cancer to breast, n= 3
• CCR original misclassification, n=2
• Corresponding notification of loco-
regional spread sent to CCR, n=36      
• Corresponding notification of distant 
spread sent to CCR, but attributed to 
non-breast primary, n=17  
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